As per the latest report published by Growth Plus Reports, the Global Allergic Conjunctivitis Market was valued at US$ 2.43 billion in 2021 and is expected to reach US$ 3.70 billion by 2030 at a revenue CAGR of 4.8% during the forecast period 2022 to 2030. The study analyzes the developmental strategies, drivers and opportunities, market trends, competitive landscape, market size, statistics, forecasts, and key investment areas.
Key Takeaways:
- The modern ocular allergy treatments R&D activities to support market revenue growth.
- Expanding patient populations are driving the need for efficient treatments.
- Exposure to pollutants and chemicals is expected to be a driver of the allergic conjunctivitis market revenue.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/allergic-conjunctivitis-market/7892
Market Drivers:
The prevalence of allergic conjunctivitis is expected to rise during the forecast period, propelling the growth of the global allergic conjunctivitis market. Due to the growth in both the patient population suffering from the ailment and the need for healthcare services, the market revenue for allergic conjunctivitis has expanded. The major market players also focused more on the creation of drugs to treat allergic conjunctivitis, which supported the growth of market revenue share. However, the unfavorable side effects of drugs for allergic conjunctivitis restrict market revenue growth to some extent.
Market Segmentation:
Growth plus reports have analyzed the global allergic conjunctivitis market from perspectives such as disease type, drug class, distribution channel, and region.
Disease Type Segmentation:
Based on disease type, the global allergic conjunctivitis market is segmented into mild allergic conjunctivitis and severe allergic conjunctivitis.
The severe allergic conjunctivitis segment dominates the global allergic conjunctivitis market in terms of large revenue share. This significant revenue share is attributed to the use of powerful and sophisticated prescription medications for an extended period to treat severe allergic conjunctivitis, which raises the associated medical costs.
Drug Class Segmentation:
Based on drug class, the global allergic conjunctivitis market is segmented into antihistamines & mast cell stabilizers, corticosteroids, and others.
The antihistamines & mast cell stabilizers segment is expected to dominate the global allergic conjunctivitis market. Key market players are concentrating on expansion methods like FDA approvals, which are anticipated to fuel segment growth over the course of the forecast year.
Distribution Channel Segmentation:
Based on distribution channels, the global allergic conjunctivitis market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies.
The hospital pharmacies segment dominates the global market in terms of the largest revenue share. This large revenue share is attributed to the high sales of prescription drugs for ocular allergies.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/allergic-conjunctivitis-market/7892
Regional Growth Dynamics:
Based on region, the global allergic conjunctivitis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America is expected to dominate the global conjunctivitis market in terms of the largest revenue share during the forecast period. The large revenue share is attributed to many patients with ophthalmic allergies in this region. Additionally, the presence of key competitors, encouraging the introduction of novel and sophisticated drugs, and favorable reimbursements are contributing to the market’s revenue expansion.
Competitive Landscape:
The prominent players operating in the global allergic conjunctivitis market are: –
- Eton Pharmaceutical
- Ocular Therapeutix, Inc.
- Eyevance Pharmaceuticals LLC
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Allergan PLC
- Atopix Therapeutics Ltd.
- Alcon
- Santen Pharmaceutical Co., Ltd.
- Auven Therapeutics
Prominent players have adopted the latest products, product approval, and agreement as crucial developmental methods to broaden the product portfolio in the global allergic conjunctivitis market. These initiatives have expanded commercial and economic opportunities and raised the demand for the allergic conjunctivitis market further.
Recent Developments:
- In August 2022, the launch of RYALTRISTM (olopatadine hydrochloride and mometasone furoate nasal spray) was approved RYALTRISTM for the treatment of seasonal allergic rhinitis (SAR) symptoms in adult and pediatric patients aged 12 and older.
- In April 2022, Sandoz, a global leader in generic and biosimilar medicines, announced the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL ALLERGIC CONJUNCTIVITIS MARKET – ANALYSIS & FORECAST, BY DISEASE TYPE
- Mild Allergic Conjunctivitis
- Severe Allergic Conjunctivitis
- GLOBAL ALLERGIC CONJUNCTIVITIS MARKET – ANALYSIS & FORECAST, BY DRUG CLASS
- Antihistamines & Mast Cell Stabilizers
- Corticosteroids
- Others
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-7892
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse related reports:
Neurological Biomarkers Market by Type (Genomic, Metabolomic, Proteomic, Imaging), by Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis), and by End-user (Hospital & Laboratories, Independent Diagnostic Centers, Research Organization) – Global Outlook & Forecast 2022-2030
Compression Bandages Market by Product (Long Stretch Bandages, Short Stretch Bandages, Multilayer Bandages), by Material (Polyester, Cotton, Latex, Others), by Application (Wound Management, Lymphedema, Deep Vein Thrombosis, Others) – Global Outlook & Forecast 2022-2030
Dental CAD/CAM Market by Product (Equipment and Software), by Type (Chair-side CAD/ CAM Systems and Laboratory CAD/CAM Systems), by Application (Dental Implant, Dental Bridges, Dental Alignment, and Others), by End-User (Dental Hospitals & Clinics, Dental Laboratories, Research Institute, and Others) – Global Outlook & Forecast 2022-2030
Knee Replacement Market by Surgery Types (Traditional Surgery, Robot Assisted Surgery), by Implants (Mobile-Bearing Implants, Fixed-Bearing Implants, Medial Pivot Implants, Customized Implants), by Replacement Types (Total Knee Replacement, Partial Knee Replacement, Revision Replacement), by Materials (Ceramic-on-Plastic, Metal-on-Plastic, Metal-on-Metal, Ceramic-on-Ceramic), and by End User (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics) – Global Outlook & Forecast 2022-2030
Electrophysiology Devices Market by Devices (Diagnostic Devices, Treatment Devices), by Indication (Atrial Fibrillation (AF), Atrioventricular Nodal Re-entry Tachycardia, Bradycardia, Wolff-Parkinson-White Syndrome (WPW), Supraventricular Tachycardia, Others), and End-user (Hospitals, Ambulatory Surgical Center, Specialty Clinics, Other) – Global Outlook & Forecast 2022-2030
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
Contact:
Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
256 Chapman Road
STE 105-4, Newark,
New Castle – 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/